Salem Radio Network News Saturday, July 24, 2021


Cuba encouraged by early trials of homegrown COVID-19 vaccine

HAVANA (Reuters) – Cuba’s Soberana 2 vaccine candidate has shown 62% efficacy with just two of its three doses, state-run biopharmaceutical corporation BioCubaFarma said on Saturday, citing preliminary data from late phase trials.

Cuba, which has a decades-old reputed biotech sector, has five vaccine candidates in clinical trials, of which two – Soberana 2 and Abdala – are in late phase trials.

(Reporting by Anett Rios; Writing by Sarah Marsh; Editing by David Gregorio)


Editorial Cartoons

View More »

Gary Varvel
Wed, Jul 14, 2021